Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Lifecore Biomedical, Inc. - Common Stock
(NQ:
LFCR
)
5.020
-0.080 (-1.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Lifecore Biomedical, Inc. - Common Stock
< Previous
1
2
Next >
Lifecore Biomedical Announces Pending Change of Auditor and Provides Expectation for Business Update
March 26, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Class Action Lawsuit Investigation News – Potential to Make Claim, Recover Losses, Contact Johnson Fistel, LLP
March 24, 2024
From
Johnson Fistel, LLP
Via
Business Wire
LIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating Lifecore Biomedical, Inc. on Behalf of Lifecore Stockholders and Encourages Investors to Contact the Firm
March 22, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Lifecore Biomedical, Inc. (LFCR)
March 21, 2024
From
Kirby McInerney LLP
Via
Business Wire
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
March 20, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Completes Restatements and Files Form 10-K for Fiscal Year 2023
March 20, 2024
Efforts now aligned toward the completion of its First Quarter Fiscal 2024 Report on Form 10-Q
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal
February 16, 2024
Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company’s Securities
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
January 12, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
January 05, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Provides Business Update
December 13, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Company Reaches Favorable Resolution Regarding Previously-Disclosed Investigation of Formerly-Held Subsidiary Yucatan Foods
November 20, 2023
U.S. Department of Justice Declines Prosecution
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
October 18, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Provides Update for Development Portfolio and Timing of Delayed Filings
October 10, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results
August 31, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT
August 22, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
August 22, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
June 01, 2023
Going concern qualification is removed as a result of the $150 million new financing transaction announced last week
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
May 22, 2023
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Sets Third Quarter 2023 Earnings Conference Call for June 1, 2023 at 7:30 a.m. CT
May 22, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
April 14, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Announces Sale of Curation Foods’ O Olive Oil and Vinegar® Business
April 06, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Signs Term Sheet with Existing Long-Term Customer to Expand CDMO Relationship
March 16, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Announces Intent to Explore Strategic Alternatives
March 16, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Reports Second Quarter Fiscal Year 2023 Results
March 16, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Announces Sale of Curation Foods’ Avocado Products Business
February 07, 2023
Proceeds to be used for debt paydown
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Receives Notice from Nasdaq Regarding Delayed Quarterly Report
January 11, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities
January 09, 2023
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Lifecore Biomedical Raises Capital for Growth with Existing Stockholder
November 25, 2022
$5 million PIPE supports near-term capital needs to meet equipment milestones
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.